This course has expired. View available courses.
Mental Health
Schizophrenia and Bipolar 1 Disorder: Using Long-Acting Injectables – Canadian Council On Continuing Education In Pharmacy (CCCEP)
DURATION
PROFESSION
# OF CREDITS
1
ACCREDITATION
EXPIRY DATE
2019-06-22
Learning objectives
After completion of the program, participants will be able to:
- Distinguish common atypical antipsychotic medications, including long-acting injectables, based on mechanism of action, adverse effects and mode of administration
- Propose strategies to maximize functionality and prevent relapses for patients with schizophrenia or bipolar 1 disorder
- Support patients with schizophrenia and bipolar 1 disorder in achieving their therapeutic goals
Cost of course:
Free